Search

Search Constraints

You searched for: Author/Creator Bortlik, M

Search Results

3. P460 Impact of anti-TNFα exposure during pregnancy for maternal inflammatory bowel disease on serologic response to vaccination of exposed children. (16th January 2018)

4. P487 Early vedolizumab trough levels are not associated with a short-term response in patients with inflammatory bowel disease. (25th January 2019)

6. P641 Ustekinumab efficiency as a higher-line therapy in association with serum levels in patients with Crohn's disease. (25th January 2019)

7. P734 Anti-TNFa exposure during pregnancy is not associated with increased infection risk in exposed children during the first year of life. (16th January 2018)

8. Switching From Originator Adalimumab to the Biosimilar SB5 in Patients With Inflammatory Bowel Disease: Short-term Experience From a Single Tertiary Clinical Centre. (6th January 2020)